Healthcare -
Biotechnology - NASDAQ - GB
$ 0.53
-1.85 %
$ 22.6 M
Market Cap
-3.12
P/E
ADAP - CASH FROM OPERATIONS
Cash from Operations ADAP - Adaptimmune Therapeutics plc
-141 M
LAST VALUE
-275.91%
2 YEAR CAGR
-6.18%
5 YEAR CAGR
-33.62%
10 YEAR CAGR